Solid Biosciences (SLDB) Tops Q4 EPS by 17c
Tweet
Share
E-mailGet Alerts SLDB Hot Sheet
Join SI Premium – FREE
Solid Biosciences (NASDAQ: SLDB) reported Q4 EPS of ($0.53), $0.17 better than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Solid Biosciences (SLDB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance
- Jackson Financial secures $1.25B revolving credit facility
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
